Prelude Capital Management’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,945
| Closed | -$220K | – | 1215 |
|
|
2025
Q2 | $220K | Sell |
2,945
-558
| -16% | -$43.8K | 0.02% | 767 |
|
|
2025
Q1 | $309K | Sell |
3,503
-2,337
| -40% | -$221K | 0.02% | 696 |
|
|
2024
Q4 | $533K | Buy |
5,840
+2,985
| +105% | +$306K | 0.03% | 576 |
|
|
2024
Q3 | $320K | Sell |
2,855
-173
| -6% | -$17.3K | 0.02% | 836 |
|
|
2024
Q2 | $297K | Sell |
3,028
-871
| -22% | -$86.4K | 0.02% | 798 |
|
|
2024
Q1 | $391K | Buy |
+3,899
| New | +$343K | 0.02% | 751 |
|
|
2022
Q4 | – | Sell |
-5,685
| Closed | -$404K | – | 1405 |
|
|
2022
Q3 | $404K | Buy |
+5,685
| New | +$511K | 0.01% | 739 |
|
|
2022
Q1 | – | Sell |
-2,532
| Closed | -$306K | – | 1936 |
|
|
2021
Q4 | $306K | Buy |
+2,532
| New | +$282K | 0.01% | 1307 |
|
|
2021
Q2 | – | Sell |
-2,136
| Closed | -$235K | – | 1711 |
|
|
2021
Q1 | $235K | Sell |
2,136
-62
| -3% | -$6.73K | 0.01% | 1258 |
|
|
2020
Q4 | $220K | Buy |
2,198
+1,292
| +143% | +$120K | 0.01% | 1063 |
|
|
2020
Q3 | $71K | Sell |
906
-6,391
| -88% | -$482K | ﹤0.01% | 1017 |
|
|
2020
Q2 | $508K | Buy |
+7,297
| New | +$460K | 0.03% | 472 |
|
|
2020
Q1 | – | Sell |
-678
| Closed | -$54K | – | 1573 |
|
|
2019
Q4 | $54K | Buy |
+678
| New | +$52.1K | ﹤0.01% | 1306 |
|
|
2017
Q4 | – | Sell |
-5,257
| Closed | -$476K | – | 1443 |
|
|
2017
Q3 | $476K | Buy |
5,257
+3,480
| +196% | +$296K | 0.04% | 390 |
|
|
2017
Q2 | $149K | Sell |
1,777
-98
| -5% | -$7.9K | 0.01% | 667 |
|
|
2017
Q1 | $152K | Sell |
1,875
-7,409
| -80% | -$583K | 0.01% | 652 |
|
|
2016
Q4 | $698K | Buy |
9,284
+5,413
| +140% | +$391K | 0.08% | 260 |
|
|
2016
Q3 | $262K | Buy |
3,871
+3,180
| +460% | +$213K | 0.03% | 481 |
|
|
2016
Q2 | $47K | Buy |
691
+323
| +88% | +$23.7K | 0.01% | 1030 |
|
|
2016
Q1 | $27K | Buy |
368
+228
| +163% | +$14.9K | ﹤0.01% | 1073 |
|
|
2015
Q4 | $9K | Buy |
+140
| New | +$9.79K | ﹤0.01% | 1266 |
|
|
2015
Q3 | – | Sell |
-536
| Closed | -$44K | – | 1552 |
|
|
2015
Q2 | $44K | Buy |
+536
| New | +$41.3K | 0.01% | 1189 |
|
|
2014
Q3 | – | Sell |
-30
| Closed | -$3K | – | 1922 |
|
|
2014
Q2 | $3K | Buy |
+30
| New | +$2.61K | ﹤0.01% | 1856 |
|
|
2013
Q4 | – | Sell |
-40
| Closed | -$3K | – | 1693 |
|
|
2013
Q3 | $3K | Buy |
+40
| New | +$3.08K | ﹤0.01% | 1577 |
|
Other funds holding EMN
Prelude Capital Management's EMN Position: Q3 2025 in Review
Prelude Capital Management sold out of Eastman Chemical (EMN) in Q3 2025, closing a stake of 2,945 shares — an estimated $220K sold.
Prelude Capital Management first reported a position in EMN in Q3 2013 and held it in 24 quarters. The position peaked at $698K in Q4 2016. 664 funds tracked by Wall St. Rank hold EMN as of Q3 2025.
- Prelude Capital Management reported no remaining Eastman Chemical position as of Q3 2025 after selling out during the quarter.
- Prelude Capital Management sold 2,945 Eastman Chemical shares in Q3 2025, an estimated $220K.
- Prelude Capital Management first reported a position in Eastman Chemical in Q3 2013 and held it in 24 quarters.
- Prelude Capital Management's Eastman Chemical position peaked at $698K in Q4 2016.
- 664 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2025.
Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.